Menlo Park, CA, United States of America

Esteban Masuda

This inventor holds 84 USPTO granted patents and 17 published patent applications, plus 12 CIPO patents and 15 EPO patents, primarily in Kinase Inhibitors (CPC class C07D498-04). Top assignees: Rigel Pharmaceuticals, Incorporated, Eli Lilly and Company. Active years: 2005-2025.

USPTO Granted Patents = 84 (Patent Applications = 17)

% Patents Active = 78.6

CIPO Patents = 12 (Patent Applications = 10)

EPO Patents = 15 (Patent Applications = 20)

Average Co-Inventor Count = 5.1

ph-index = 10

Forward Citations = 320(Granted Patents)

Forward Citations (Not Self Cited) = 221(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Company Filing History:

83 out of 491

Rigel Pharmaceuticals, Incorporated

patents

1 out of 4,507

Eli Lilly and Company

patents

Years Active: 2005-2025

Loading Chart...

Areas of Expertise:

IRAK Inhibitors

RIP1K Inhibitors

Tyrosine Kinase Inhibitors

Protein Kinase C Inhibitors

Autoimmune Diseases

JAK Pathway

Pyrimidine Compounds

Prodrugs

84 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12459941 - Tricyclic IRAK inhibitors (2025-11-04),

2. 12384775 - Pyrimid-2-yl-pyrazole compounds as IRAK inhibitors (2025-08-12),

3. 12297202 - RIP1K inhibitors (2025-05-13),

4. 12263180 - Method for treatment of COVID-19-associated conditions (2025-04-01),

5. 12116354 - RIP1 inhibitory compounds and methods for making and using the same (2024-10-15),

6. 11919890 - RIP1 inhibitory compounds and methods for making and using the same (2024-03-05),

7. 11672791 - Tyrosine kinase inhibitors (2023-06-13),

8. 11667643 - RIP1K inhibitors (2023-06-06),

9. 11667611 - Compositions and methods for inhibition of the JAK pathway (2023-06-06),

10. 11472782 - RIP1 inhibitory compounds and methods for making and using the same (2022-10-18),

11. 11377428 - RIP1 inhibitory compounds and methods for making and using the same (2022-07-05),

12. 11370765 - RIP1 inhibitory compounds and methods for making and using the same (2022-06-28),

13. 11370764 - RIP1 inhibitory compounds and methods for making and using the same (2022-06-28),

14. 11332451 - RIP1 inhibitory compounds and methods for making and using the same (2022-05-17),

15. RE48898 - Prodrugs of 2,4-pyrimidinediamine compounds and their uses (2022-01-24),

Title: The Innovative Journey of Esteban Masuda

Introduction:

Esteban Masuda, a visionary inventor based in Menlo Park, CA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents:

Esteban Masuda's latest patents include a cutting-edge artificial intelligence algorithm for autonomous vehicles and a revolutionary wearable device for monitoring health metrics in real-time.

Career Highlights:

With a background in computer science and engineering, Esteban Masuda has worked for top tech companies in Silicon Valley, where he honed his skills in developing cutting-edge technologies. His passion for innovation has led to the creation of several patented inventions that have transformed industries.

Collaborations:

Throughout his career, Esteban Masuda has collaborated with leading researchers and engineers to push the boundaries of technological advancement. His collaborative spirit and innovative mindset have resulted in successful projects that have garnered international recognition.

Conclusion:

Esteban Masuda's relentless pursuit of innovation and his commitment to pushing the limits of technology make him a true pioneer in the field of inventions. His impact on the tech industry continues to inspire future generations of inventors and innovators.